M. Jeter

发表

Phase II trial of concurrent atezolizumab with chemoradiation in unresectable non-small cell lung cancer.

Joe Y. Chang, P. Thall, D. Gomez, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Long‐Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial

Joe Y. Chang, D. Gomez, P. Balter, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.

Joe Y. Chang, T. Guerrero, K. Forster, 2007, International journal of radiation oncology, biology, physics.

Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study

Tinsu Pan, Qiuling Shi, Charles S Cleeland, 2018, Quality of Life Research.

Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.

J. Ajani, S. Swisher, T. Buchholz, 2009, International journal of radiation oncology, biology, physics.

Gemcitabine-induced radiation recall.

P. Wen, P. Jänne, R. Salgia, 2002, International journal of radiation oncology, biology, physics.

Radiation Time, Dose, and Fractionation in the Treatment of Lung Cancer

D. Gomez, R. Komaki, J. Cox, 2011 .

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection.

Joe Y. Chang, T. Guerrero, J. Roth, 2004, International journal of radiation oncology, biology, physics.

Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer

Joe Y. Chang, K. Ahrar, D. Gomez, 2018, JAMA network open.

Stereotactic Ablative Radiotherapy is a Highly Effective Treatment for Early Stage Non-Small Cell Lung Cancer in Elderly Patients

Joe Y. Chang, J. Welsh, J. Heymach, 2018 .

Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer.

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2018, International journal of radiation oncology, biology, physics.

7‐year follow‐up after stereotactic ablative radiotherapy for patients with stage I non–small cell lung cancer: Results of a phase 2 clinical trial

Joe Y. Chang, J. Roth, D. Gomez, 2017, Cancer.

Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19☆

Steven H. Lin, A. Koong, M. McAleer, 2020, Radiotherapy and Oncology.

Long-term outcomes of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017 .

4-D CT Based and Daily In-room CT-guided Stereotactic Body Radiotherapy (SBRT) for Lung Cancer

Lei Dong, P. Balter, M. McAleer, 2007 .

O-152 Analysis of acute toxicity results of intensity modulated radiationtherapy (IMRT) in the treatment of non-small cell lung cancer (NSCLC)

Joe Y. Chang, T. Guerrero, C. Stevens, 2005 .

Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer

T. Guerrero, C. Stevens, R. Komaki, 2005 .

Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer

D. Gomez, Z. Liao, S. Hahn, 2017, Oncotarget.

Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer.

Joe Y. Chang, K. Hess, J. Welsh, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.

Joe Y. Chang, T. Guerrero, R. Herbst, 2007, International journal of radiation oncology, biology, physics.

Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis.

Joe Y. Chang, D. Gomez, Steven H. Lin, 2020, International journal of radiation oncology, biology, physics.

Treatment planning system evaluation for mesothelioma IMRT.

K. Forster, C. Stevens, X. Zhu, 2005, Lung cancer.

High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial Symptom

Steven H. Lin, D. Hui, Kara J Thompson, 2021 .

High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial Symptom

D. Hui, Mattei, Juan Lopez, 2021 .

Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial.

C. Fuller, J. Welsh, R. Komaki, 2019, JAMA oncology.

Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.

R. Mohan, Xiaodong Zhang, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience

Joe Y. Chang, T. Guerrero, J. Ajani, 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Four-dimensional CT- and On-board Volumetric Image-guided Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer

J. Roth, S. Swisher, P. Balter, 2011 .

Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non–Small Cell Lung Cancer: Final Results of a Phase 2 Study

Joe Y. Chang, R. Mohan, Xiaodong Zhang, 2017, JAMA oncology.

Significantly Reduced Normal Tissue Dose with Proton Radiotherapy Compared with 3D-CRT or IMRT in Stage I or Stage III Non-Small Cell Lung Cancer

R. Mohan, R. Komaki, Z. Liao, 2005 .

Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery.

Joe Y. Chang, J. Roth, J. Welsh, 2021, The Lancet. Oncology.

Metabolic Responses to Metformin in Inoperable Early-stage Non–Small Cell Lung Cancer Treated With Stereotactic Radiotherapy

Joe Y. Chang, T. Guerrero, Steven H. Lin, 2020, American Journal of Clinical Oncology.

Incidence of Second Malignancy after Successful Treatment of Limited‐Stage Small–Cell Lung Cancer and Its Effects on Survival

J. Welsh, Steven H. Lin, R. Komaki, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?

Joe Y. Chang, S. McGovern, M. McAleer, 2009, Cancer.

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

Joe Y. Chang, P. Thall, Steven H. Lin, 2020 .

Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer.

Zhongxing Liao, Pierre Blanchard, Z. Liao, 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.

Joe Y. Chang, R. Mohan, J. Ajani, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.

Joe Y. Chang, J. Ajani, D. Gomez, 2017, International journal of radiation oncology, biology, physics.

Phase I/II Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage Small Cell Lung Cancer.

Joe Y. Chang, K. Hess, J. Welsh, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer

Joe Y. Chang, Zhongxing Liao, James D. Cox, 2011, Front. Oncol..

Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.

Joe Y. Chang, T. Guerrero, J. Ajani, 2005, International journal of radiation oncology, biology, physics.

Intensity-modulated radiation therapy for mesothelioma: impact of multileaf collimator leaf width and pencil beam size on planning quality and delivery efficiency.

Karl Prado, Zhongxing Liao, Craig W Stevens, 2005, International journal of radiation oncology, biology, physics.

Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study

Joe Y. Chang, J. Welsh, Steven H. Lin, 2021, Clinical and translational radiation oncology.

A Phase I Clinical Trial of Thoracic Radiotherapy and Concurrent Celecoxib for Patients with Unfavorable Performance Status Inoperable/Unresectable Non–Small Cell Lung Cancer

Joe Y. Chang, T. Guerrero, R. Komaki, 2005, Clinical Cancer Research.

Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non‐small cell lung cancer

D. Gomez, R. Komaki, Z. Liao, 2018, Cancer medicine.

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer.

Joe Y. Chang, D. Gomez, J. Welsh, 2017, International Journal of Radiation Oncology, Biology, Physics.

Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer.

Radhe Mohan, Joe Y. Chang, Daniel Gomez, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Outcomes with Esophageal Cancer Radiation Therapy

Joe Y. Chang, J. Ajani, S. Swisher, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

Joe Y. Chang, Lei Dong, Zhongxing Liao, 2008, International journal of radiation oncology, biology, physics.

IMRT reduces lung irradiation in distal esophageal cancer over 3D CRT

T. Guerrero, R. Mohan, C. Stevens, 2003 .

High Flow Nasal Cannula Therapy for Exertional Dyspnea in Cancer Patients: A Pilot Randomized Clinical Trial.

E. Bruera, K. Hess, D. Gomez, 2020, The oncologist.

Results of a Phase II Randomized Trial of Proton Beam Therapy vs Intensity Modulated Radiation Therapy in Esophageal Cancer

P. Thall, R. Mohan, J. Ajani, 2019, International Journal of Radiation Oncology*Biology*Physics.

The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non–Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy

D. Gomez, Z. Liao, L. Levy, 2017, Translational oncology.

Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non – Small Cell Lung Cancer ( NSCLC ) Receiving

Z. Liao, L. Levy, Yipeng Song, 2017 .

Corrigendum to “Treatment planning system evaluation for mesothelioma IMRT” [Lung Cancer 49S1 (2005) S75–S81]

K. Forster, C. Stevens, X. Zhu, 2005 .

Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline.

P. Iyengar, M. Berry, D. de Ruysscher, 2023, Practical radiation oncology.

Early Results of Stereotactic Body Radiation Therapy (SBRT) in Centrally/Superiorly Located Stage I or Isolated Recurrent NSCLC

P. Balter, M. McAleer, M. Bucci, 2008 .

Preserving functional lung using perfusion imaging and intensity-modulated radiation therapy for advanced-stage non-small cell lung cancer.

Thomas Guerrero, Radhe Mohan, Zhongxing Liao, 2007, International journal of radiation oncology, biology, physics.

Pulmonary Function Tests Before and After Stereotactic Radiation of the Lung

T. Guerrero, P. Balter, M. McAleer, 2007 .

Lung Perfusion Imaging Can Risk Stratify Lung Cancer Patients for the Development of Pulmonary Complications after Chemoradiation

Joe Y. Chang, Katsuhiro Kobayashi, R. Komaki, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.